Introduction The landscape of glaucoma care in the United States is shifting rapidly. With the aging population growing and glaucoma cases on the rise, eye care professionals are under increasing pressure to deliver faster, more accurate, and more accessible diagnostics. Perimetry, the gold standard for detecting and monitoring glaucoma, is central to this challenge. However, traditional visual field testing (VFT) systems often slow down clinical workflows and create barriers

Introduction Artificial intelligence is not the future of ophthalmology, it’s already reshaping it. Glaucoma, the leading cause of irreversible blindness, affects more than 80 million people worldwide. Among them, primary open-angle glaucoma (POAG) alone impacts 57.5 million individuals, with prevalence strongly correlated with age.  In Europe, over 7.8 million people were affected in 2020, and in Switzerland, it's estimated that up to 100,000 people live with glaucoma, often

VisionOne™ was built to change that. Created by PeriVision in partnership with Switzerland’s largest eye clinic, the Inselspital, VisionOne™ is a VR-based visual field testing platform designed for speed, accessibility, and clinical precision. It brings together patented AI, portable user-friendly hardware, and intuitive software to reimagine how glaucoma is detected and monitored.

Eye health is emerging as one of the most overlooked public health priorities of our time. In 2025, nearly one in four people globally are living with some form of vision impairment, and the numbers are rising. The drivers? Aging populations, Lifestyle-related diseases like diabetes, Limited access to preventive eye care. But here’s the paradox: up to 50% of vision loss is preventable with early detection and proper treatment. So why are millions still going undiagnosed?